Last 8,750 KRW
Change Today -300.00 / -3.31%
Volume 4.1M
As of 2:29 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for daehan new pharm co ltd (054670)

Year over year, Daehan New Pharm Co., Ltd. has seen their bottom line shrink from a gain of 643.6M KRW to a loss of 5.5B KRW despite an increase in revenues from 44.5B KRW to 48.0B KRW. An increase in the percentage of sales devoted to SGA costs from 40.16% to 44.20% was a key component in the falling bottom line in the face of rising revenues.
View Income Statement In U.S. Dollar
Currency in
Millions of South Korean Wons
As of:Dec 31
2009
Reclassified
KRW
Dec 31
2010
KRW
Dec 31
2011
Press
Release

KRW
Dec 31
2012
Press
Release

KRW
4 Year
Trend
Revenues40,403.349,647.244,522.748,010.2
TOTAL REVENUES40,403.349,647.244,522.748,010.2
Cost of Goods Sold21,933.325,211.721,285.523,336.7
GROSS PROFIT18,469.924,435.623,237.224,673.5
Selling General & Admin Expenses, Total13,627.618,539.717,879.521,222.5
R&D Expenses127.8856.6----
Depreciation & Amortization, Total161.4133.4----
Other Operating Expenses311.9342.3----
OTHER OPERATING EXPENSES, TOTAL14,228.619,871.917,879.521,222.5
OPERATING INCOME4,241.34,563.75,357.73,451.0
Interest Expense-1,743.2-2,090.3-3,074.4-3,388.9
Interest and Investment Income1,809.1197.9173.2214.5
Other Non-Operating Expenses, Total-1,996.0-5,993.8-1,523.5-5,739.6
Other Non-Operating Income (Expenses)193.3-5,448.2-1,523.5-5,739.6
Gain (Loss) on Sale of Assets38.80.8----
EBT, INCLUDING UNUSUAL ITEMS2,350.1-3,321.7932.9-5,463.0
Income Tax Expense734.8-550.7289.465.9
Earnings from Continuing Operations1,615.3-2,771.0643.6-5,528.9
EARNINGS FROM DISCOUNTINUED OPERATIONS-1,254.6------
NET INCOME360.7-2,771.0643.6-5,528.9
NET INCOME TO COMMON INCLUDING EXTRA ITEMS360.7-2,771.0643.6-5,528.9
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS1,615.3-2,771.0643.6-5,528.9
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
054670:KS 8,750.00 KRW -300.00

054670 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 054670.
View Industry Companies
 

Industry Analysis

054670

Industry Average

Valuation 054670 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.5x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.5x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEHAN NEW PHARM CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.